Clinical Trial

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Study acronym: EU-PNAFLD
Recruiting
View on ClinicalTrials.gov →
Summary
The EU-PNAFLD (The European Paediatric NALFD Registry) will be a network composed of European centres involved in the care of children with NAFLD, and will include Hepatologists, Endocrinologists, and Scientists, supported by relevant international specialists. This collaboration will build on existing infrastructure (local databases and bio-repositories) and will align with the adult European NAFLD Registry ("EPoS", Elucidating Pathways of Steatohepatitis study) to allow long-term follow-up supported by translational studies. Through an international, well-characterised large-scale cohort, we hope to: facilitate multi-centre clinical trials; extend our understanding of the key disease mechanisms of NAFLD; and establish the natural history of paediatric NAFLD.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-12-05; most recent amendment 2022-02-17.
Trial Details
NCT Number NCT04190849
Lead Sponsor Cambridge University Hospitals NHS Foundation Trust
Collaborators: The European Association for the Study of the Liver, Children's Liver Disease Foundation
Conditions Non-Alcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver, Non-alcoholic Steatohepatitis
Enrollment 2,000 participants
Start Date 2017-11-14
Primary Completion 2047-11 (estimated)
Study Completion 2047-11 (estimated)
Updated on ClinicalTrials.gov 2022-03-04